Skip to main content
eScholarship
Open Access Publications from the University of California

UC San Diego

UC San Diego Previously Published Works bannerUC San Diego

Targeting Plasmodium PI(4)K to eliminate malaria.

  • Author(s): McNamara, Case W
  • Lee, Marcus Cs
  • Lim, Chek Shik
  • Lim, Siau Hoi
  • Roland, Jason
  • Simon, Oliver
  • Yeung, Bryan Ks
  • Chatterjee, Arnab K
  • McCormack, Susan L
  • Manary, Micah J
  • Zeeman, Anne-Marie
  • Dechering, Koen J
  • Kumar, Tr Santha
  • Henrich, Philipp P
  • Gagaring, Kerstin
  • Ibanez, Maureen
  • Kato, Nobutaka
  • Kuhen, Kelli L
  • Fischli, Christoph
  • Nagle, Advait
  • Rottmann, Matthias
  • Plouffe, David M
  • Bursulaya, Badry
  • Meister, Stephan
  • Rameh, Lucia
  • Trappe, Joerg
  • Haasen, Dorothea
  • Timmerman, Martijn
  • Sauerwein, Robert W
  • Suwanarusk, Rossarin
  • Russell, Bruce
  • Renia, Laurent
  • Nosten, Francois
  • Tully, David C
  • Kocken, Clemens Hm
  • Glynne, Richard J
  • Bodenreider, Christophe
  • Fidock, David A
  • Diagana, Thierry T
  • Winzeler, Elizabeth A
  • et al.
Abstract

Achieving the goal of malaria elimination will depend on targeting Plasmodium pathways essential across all life stages. Here we identify a lipid kinase, phosphatidylinositol-4-OH kinase (PI(4)K), as the target of imidazopyrazines, a new antimalarial compound class that inhibits the intracellular development of multiple Plasmodium species at each stage of infection in the vertebrate host. Imidazopyrazines demonstrate potent preventive, therapeutic, and transmission-blocking activity in rodent malaria models, are active against blood-stage field isolates of the major human pathogens P. falciparum and P. vivax, and inhibit liver-stage hypnozoites in the simian parasite P. cynomolgi. We show that imidazopyrazines exert their effect through inhibitory interaction with the ATP-binding pocket of PI(4)K, altering the intracellular distribution of phosphatidylinositol-4-phosphate. Collectively, our data define PI(4)K as a key Plasmodium vulnerability, opening up new avenues of target-based discovery to identify drugs with an ideal activity profile for the prevention, treatment and elimination of malaria.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
Current View